Cointime

Entelos

company

About

Entelos is a provider of predictive biosimulation for drug discovery and development.

  • 11 - 50

Highlights

Total Funding Amount
$25M
Funding Rounds
1
Investors
1

Details

Last Funding Type
Series C
Last Funding Money Raised
$25M
Industries
Biotechnology,Health Care,Therapeutics
Founded date
Jan 1, 1996
Number Of Employee
11 - 50
Operating Status
Active

Entelos is the leading provider of predictive biosimulation for drug discovery and development. We provide advanced biosimulation capabilities that make discovery more efficient and increase clinical success.

For over 15 years, we have enabled R&D organizations to predict better paths to success by simulating systems biology. Our solutions include mechanism-based, mathematical models; virtual patients and populations; biosimulation software; and biosimulation expertise.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$25M
Entelos has raised a total of $25M in funding over 2 rounds. Their latest funding was raised on Sep 6, 2001 from a Series C round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Sep 6, 2001 Series C $25M 1 Bear Stearns Health Innoventures L.P — Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Entelos is funded by 1 investors. Bear Stearns Health Innoventures L.P are the most recent investors.
Investor Name Lead Investor Funding Round
Bear Stearns Health Innoventures L.P Yes Series C
Cointime
Содержание
компания